Queue: Revolutionizing Pharmacy with Autonomous Robot Kiosks
Startup Queue has made a groundbreaking entrance into the healthcare landscape by introducing the first fully autonomous robot pharmacy. This innovation takes the form of prescription drug kiosks, designed to streamline and optimize the dispensing of medications without the need for on-site pharmacists.
Significant Funding and Strategic Partnerships
The Bay Area-based company has successfully secured $12.6 million in a seed funding round led by AlleyCorp. Prior to this, Queue raised $6 million in pre-seed funding spearheaded by Riot Ventures. Other notable investors include House Capital, Ubiquity Ventures, Grep Ventures, and Banter Capital. This robust financial backing highlights the market’s confidence in Queue’s potential to transform pharmacy operations.
Queue has also collaborated with a major national pharmacy chain, providing a working prototype that has already yielded early commercial validation. This partnership underscores the startup’s commitment to establishing a strong foothold in the pharmacy sector.
Expansion and Development Plans
With the new capital injection, Queue plans to accelerate product development and expand deployment to corporate pharmacy customers. Additionally, the company aims to bolster its engineering team, which currently consists of 20 engineers based in Silicon Valley. Active recruitment is ongoing in the fields of robotics, hardware, software, and pharmaceuticals.
Leadership and Innovation
Queue was co-founded by healthcare entrepreneur Nick Desai and Josh Liu, each bringing a wealth of experience to the venture. Desai, a seasoned entrepreneur, previously co-founded Heal, a startup acquired by Humana in 2023, and Together by Renee, an AI-powered health app acquired by Cairns Health. Liu, having honed his skills at Tesla and Zipline, serves as the chief technology officer at Queue.
An Autonomous Solution to Pharmacy Challenges
Queue’s autonomous system is capable of accepting sealed wholesale pill bottles at one end and delivering filled, verified prescription bottles at the other. The platform currently supports 250 of the most commonly prescribed medications in the United States. By employing computer vision, the kiosks accurately identify each pill based on its National Drug Code (NDC) and prescription information.
The company claims its robotic system can reduce medication dispensing costs by up to 96% compared to traditional pharmacy operations. This technology is adaptable for use in various settings, including retail locations, hospitals, and rural communities, where access to pharmacies is often limited.
Addressing Industry Challenges
America’s pharmacies are grappling with labor shortages and economic pressures. According to the National Community Pharmacists Association, over 75% of community pharmacists report difficulties in filling open positions. Additionally, 73% of full-time pharmacists rated their workload as “high” or “excessively high” in 2024, a notable increase from 66% in 2014, according to the National Pharmacy Workforce Study.
Data from the NCPA and the University of Southern California reveals that one in eight neighborhoods in the U.S. are classified as pharmacy deserts. In response to these challenges, Queue positions its autonomous prescription fulfillment as a crucial infrastructure layer for American healthcare, aiming to enhance patient access while improving economic efficiency.
Market Reception and Future Prospects
Queue’s innovative approach to pharmacy operations has garnered attention and support from industry leaders. “What the Queue team has accomplished is rare in healthcare hardware development,” said Abe Murray, general partner at AlleyCorp. “We decided to lead this round of funding because we believe Queue is building critical infrastructure that can both improve patient access to the prescriptions they need and leverage robotics and automation to significantly improve labor constraints that exist in pharmacies.”
The introduction of Queue’s autonomous robot kiosks marks a significant step forward in addressing the structural challenges faced by the pharmacy industry. As the company continues to expand and refine its technology, it is well-positioned to become a pivotal player in reshaping how medications are dispensed and accessed across the United States.
For further information, visit the source: Here.
“`
